4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000108
Director sold 1,666 shares at an average $52.81 ($87,983)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2021-11-10 | Sale | −1,006 | $52.49 | $52,805 | 126,827 | D: show line 1 in the form |
| SATO VICKI L Director | 2021-11-10 | Sale | −660 | $53.30 | $35,178 | 126,167 | D: show line 2 in the form |
| Open-market sales · 1,666 sh · avg $52.81 · $87,983 | |||||||
Loading xslF345X03/wf-form4_163675267254090.xml…